| Trial ID: | L5415 |
| Source ID: | NCT01416649
|
| Associated Drug: |
Exenatide
|
| Title: |
Impact of Exenatide on Sleep Duration
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Exenatide
|
| Outcome Measures: |
Primary: Sleep duration and sleep efficiency, Sleep duration and efficiency will be measured using an activity monitor worn on the wrist., at the end of 3 months of treatment with the medication |
|
| Sponsor/Collaborators: |
Sponsor: University of Chicago
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
8
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2011-02-01
|
| Completion Date: |
2021-04-21
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-26
|
| Locations: |
The University of Chicago, Chicago, Illinois, 60637, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01416649
|
